Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Genetic complementation screen identifies a mitogen-activated protein kinase phosphatase, MKP3, as a regulator of dopamine transporter trafficking.
Mortensen OV
,
Larsen MB
,
Prasad BM
,
Amara SG
.
???displayArticle.abstract???
The antidepressant and cocaine sensitive plasma membrane monoamine transporters are the primary mechanism for clearance of their respective neurotransmitters and serve a pivotal role in limiting monoamine neurotransmission. To identify molecules in pathways that regulate dopamine transporter (DAT) internalization, we used a genetic complementation screen in Xenopus oocytes to identify a mitogen-activated protein (MAP) kinase phosphatase, MKP3/Pyst1/DUSP6, as a molecule that inhibits protein kinase C-induced (PKC) internalization of transporters, resulting in enhanced DAT activity. The involvement of MKP3 in DAT internalization was verified using both overexpression and shRNA knockdown strategies in mammalian cell models including a dopaminergic cell line. Although the isolation of MKP3 implies a role for MAP kinases in DAT internalization, MAP kinase inhibitors have no effect on internalization. Moreover, PKC-dependent down-regulation of DAT does not correlate with the phosphorylation state of several well-studied MAP kinases (ERK1/2, p38, and SAPK/JNK). We also show that MKP3 does not regulate PKC-induced ubiquitylation of DAT but acts at a more downstream step to stabilize DAT at the cell surface by blocking dynamin-dependent internalization and delaying the targeting of DAT for degradation. These results indicate that MKP3 can act to enhance DAT function and identifies MKP3 as a phosphatase involved in regulating dynamin-dependent endocytosis.
Alessi,
The human CL100 gene encodes a Tyr/Thr-protein phosphatase which potently and specifically inactivates MAP kinase and suppresses its activation by oncogenic ras in Xenopus oocyte extracts.
1993, Pubmed,
Xenbase
Alessi,
The human CL100 gene encodes a Tyr/Thr-protein phosphatase which potently and specifically inactivates MAP kinase and suppresses its activation by oncogenic ras in Xenopus oocyte extracts.
1993,
Pubmed
,
Xenbase
Apparsundaram,
Trafficking-dependent and -independent pathways of neurotransmitter transporter regulation differentially involving p38 mitogen-activated protein kinase revealed in studies of insulin modulation of norepinephrine transport in SK-N-SH cells.
2001,
Pubmed
Apparsundaram,
Acute regulation of norepinephrine transport: II. PKC-modulated surface expression of human norepinephrine transporter proteins.
1998,
Pubmed
Bhalla,
MAP kinase phosphatase as a locus of flexibility in a mitogen-activated protein kinase signaling network.
2002,
Pubmed
Blanchetot,
Substrate-trapping techniques in the identification of cellular PTP targets.
2005,
Pubmed
Bolan,
D2 receptors regulate dopamine transporter function via an extracellular signal-regulated kinases 1 and 2-dependent and phosphoinositide 3 kinase-independent mechanism.
2007,
Pubmed
Boschert,
Induction of the dual specificity phosphatase PAC1 in rat brain following seizure activity.
1997,
Pubmed
Brondello,
Constitutive MAP kinase phosphatase (MKP-1) expression blocks G1 specific gene transcription and S-phase entry in fibroblasts.
1995,
Pubmed
Brunet,
Nuclear translocation of p42/p44 mitogen-activated protein kinase is required for growth factor-induced gene expression and cell cycle entry.
1999,
Pubmed
Burghoorn,
Mutation of the MAP kinase DYF-5 affects docking and undocking of kinesin-2 motors and reduces their speed in the cilia of Caenorhabditis elegans.
2007,
Pubmed
Chen,
Synaptophysin enhances the neuroprotection of VMAT2 in MPP+-induced toxicity in MN9D cells.
2005,
Pubmed
Chen,
MAP kinases.
2001,
Pubmed
Choi,
Specific modulation of dopamine expression in neuronal hybrid cells by primary cells from different brain regions.
1992,
Pubmed
Chu,
The mitogen-activated protein kinase phosphatases PAC1, MKP-1, and MKP-2 have unique substrate specificities and reduced activity in vivo toward the ERK2 sevenmaker mutation.
1996,
Pubmed
Conner,
Regulated portals of entry into the cell.
2003,
Pubmed
Cousin,
The dephosphins: dephosphorylation by calcineurin triggers synaptic vesicle endocytosis.
2001,
Pubmed
Daniels,
Regulated trafficking of the human dopamine transporter. Clathrin-mediated internalization and lysosomal degradation in response to phorbol esters.
1999,
Pubmed
Dickinson,
Diverse physiological functions for dual-specificity MAP kinase phosphatases.
2006,
Pubmed
Eblaghie,
Negative feedback regulation of FGF signaling levels by Pyst1/MKP3 in chick embryos.
2003,
Pubmed
Granas,
N-terminal truncation of the dopamine transporter abolishes phorbol ester- and substance P receptor-stimulated phosphorylation without impairing transporter internalization.
2003,
Pubmed
Greene,
Gene expression profiling of rat midbrain dopamine neurons: implications for selective vulnerability in parkinsonism.
2005,
Pubmed
Holton,
Nonclassical, distinct endocytic signals dictate constitutive and PKC-regulated neurotransmitter transporter internalization.
2005,
Pubmed
Khoshbouei,
N-terminal phosphorylation of the dopamine transporter is required for amphetamine-induced efflux.
2004,
Pubmed
Kondoh,
Regulation of MAP kinases by MAP kinase phosphatases.
2007,
Pubmed
Li,
Dusp6 (Mkp3) is a negative feedback regulator of FGF-stimulated ERK signaling during mouse development.
2007,
Pubmed
Marchetti,
Extracellular signal-regulated kinases phosphorylate mitogen-activated protein kinase phosphatase 3/DUSP6 at serines 159 and 197, two sites critical for its proteasomal degradation.
2005,
Pubmed
Miller,
Dysregulation of gene expression in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse substantia nigra.
2004,
Pubmed
Miranda,
Multiple molecular determinants in the carboxyl terminus regulate dopamine transporter export from endoplasmic reticulum.
2004,
Pubmed
Miranda,
Enhanced ubiquitylation and accelerated degradation of the dopamine transporter mediated by protein kinase C.
2005,
Pubmed
Miranda,
Three ubiquitin conjugation sites in the amino terminus of the dopamine transporter mediate protein kinase C-dependent endocytosis of the transporter.
2007,
Pubmed
Mortensen,
Dynamic regulation of the dopamine transporter.
2003,
Pubmed
Morón,
Mitogen-activated protein kinase regulates dopamine transporter surface expression and dopamine transport capacity.
2003,
Pubmed
Muda,
MKP-3, a novel cytosolic protein-tyrosine phosphatase that exemplifies a new class of mitogen-activated protein kinase phosphatase.
1996,
Pubmed
Prasad,
The dopamine transporter in mesencephalic cultures is refractory to physiological changes in membrane voltage.
2001,
Pubmed
Price,
Brain protein serine/threonine phosphatases.
1999,
Pubmed
Rintelen,
The Drosophila dual-specificity ERK phosphatase DMKP3 cooperates with the ERK tyrosine phosphatase PTP-ER.
2003,
Pubmed
Samuvel,
A role for p38 mitogen-activated protein kinase in the regulation of the serotonin transporter: evidence for distinct cellular mechanisms involved in transporter surface expression.
2005,
Pubmed
Smith,
Feedback interactions between MKP3 and ERK MAP kinase control scleraxis expression and the specification of rib progenitors in the developing chick somite.
2005,
Pubmed
Sorkina,
Constitutive and protein kinase C-induced internalization of the dopamine transporter is mediated by a clathrin-dependent mechanism.
2005,
Pubmed
Sorkina,
RNA interference screen reveals an essential role of Nedd4-2 in dopamine transporter ubiquitination and endocytosis.
2006,
Pubmed
Takaki,
Two kinds of mitogen-activated protein kinase phosphatases, MKP-1 and MKP-3, are differentially activated by acute and chronic methamphetamine treatment in the rat brain.
2001,
Pubmed
Tonks,
PTP1B: from the sidelines to the front lines!
2003,
Pubmed
Torres,
Plasma membrane monoamine transporters: structure, regulation and function.
2003,
Pubmed
Tsang,
A role for MKP3 in axial patterning of the zebrafish embryo.
2004,
Pubmed
Wiland,
Purification and kinetic characterization of the mitogen-activated protein kinase phosphatase rVH6.
1996,
Pubmed
Zahniser,
Chronic and acute regulation of Na+/Cl- -dependent neurotransmitter transporters: drugs, substrates, presynaptic receptors, and signaling systems.
2001,
Pubmed
Zhu,
p38 MAPK activation elevates serotonin transport activity via a trafficking-independent, protein phosphatase 2A-dependent process.
2005,
Pubmed
Zhu,
Adenosine receptor, protein kinase G, and p38 mitogen-activated protein kinase-dependent up-regulation of serotonin transporters involves both transporter trafficking and activation.
2004,
Pubmed
